Jin Cui

Jin Cui currently serves as a Senior Scientist at Dyne Therapeutics, beginning in April 2021, after previously holding the position of Scientist. Prior experience includes a role as a Postdoctoral Researcher at Boston Children's Hospital from January 2017 to April 2021, where significant contributions included discovering inflammation propagation in the embryonic mouse brain and leading the generation of a CRISPR-Cas9 reporter mouse line. Jin Cui also worked as a Research Fellow at Harvard Medical School during the same time frame. Educational qualifications include a Doctor of Philosophy in Biochemistry and Cell Biology from the University of Chinese Academy of Sciences and a Bachelor of Science in Biology from Fudan University. Notable competencies encompass advanced microscopy, metabolomics, proteomics, and drug discovery efforts related to Alzheimer’s disease.